Fig. 1: The proposed 1000 Moroccan genome project will create a positive economic impact and demonstrate an increased cost–benefit ratio.

The predicted economic impact and cost–benefit analysis of the genomes project illustrate the projected economic benefits, long-term impacts, and cost–benefit analysis outcomes of the proposed 1000 Moroccan genomes project. A Economic Impact by Sector: shows the distribution of economic impacts across key sectors, including agriculture, fishing, research and development (R&D), education, and other sectors. The largest impacts are observed in agriculture and R&D, respectively, reflecting their central role in generating economic benefits from genome sequencing. The average agricultural contribution is 53% (the total economic impact attributed to agriculture was US$13 million, while the combined impact of all sectors amounted to ~US$24,340,000 million). The average R&D contribution is 40% (the total economic impact for R&D was $10 million, while the same overall economic impact of US$24,340,000 million). B Long-term Economic Impact Projections: illustrate the cumulative economic benefits over a 5-, 10-, and 20-year period. Sectors such as agriculture, R&D, and downstream industries exhibit significant growth, with total impacts surpassing $78 million after 20 years. This underscores the long-term sustainability of the genome sequencing investment. C Cost–benefit Analysis (10-year Projection): displays the results of the 10-year cost-benefit analysis. It highlights key metrics, including Total Cost, Discounted Cost, Total Benefit, Discounted Benefit, and net present value (NPV). The analysis reveals a Benefit–Cost ratio (BCR) of 3.29, indicating that every dollar invested generates US$3.29 in benefits, affirming the economic viability of the project.